Adrenal Gland Neoplasms - 81 Studies Found Withdrawn : Treatment Study Using Bevacizumab for Patients With Adrenocortical Carcinoma : Adrenocortical Carcinoma : 2007-05-02 : Drug: Bevacizumab Withdrawn : Sunitinib in Refractory Adrenocortical Carcinoma : Adrenocortical Carcinoma : 2007-03-28 : Drug: Sunitinib Recruiting : German Adrenocortical Carcinoma Registry : Adrenocortical Carcinoma : 2007-03-28 Completed : Trial With Taxotere and Cisplatin in Non-operable Adrenocortical Carcinoma : Adrenocortical Carcinoma : 2006-05-08 : Drug: cisplatin, taxotere cisplatin 75 mg/m2 Taxotere 75 mg/m2 Completed : Phase II Trial of ZD1839 (Iressa) in Patients With Nonresectable Adrenocortical Carcinoma (ACC) : Nonresectable Adrenocortical Carcinoma : 2005-09-15 : Drug: Iressa (ZD1839) Completed : Trial in Locally Advanced and Metastatic Adrenocortical Carcinoma Treatment (FIRM-ACT) : Carcinoma, Adrenal Cortical : 2004-10-19 : Drug: Etoposide Drug: Doxorubicin Completed : Antineoplaston Therapy in Treating Patients With Stage IV Adrenal Gland Cancer : Adrenocortical Carcinoma : 1999-11-01 : Drug: antineoplaston A10 Drug: antineoplas Terminated : S9427, Suramin in Treating Patients With Stage III or Stage IV Adrenocortical Cancer Incurable by Surgery : Adrenocortical Carcinoma : 1999-11-01 : Drug: suramin Drug: therapeutic hydrocorti Completed : A Study of Combination Chemotherapy and Surgical Resection in the Treatment of Adrenocortical Carcinoma: Continuous Infusion Doxorubicin, Vincristine and Etoposide With Daily Mitotane Before and After Surgical Resection : Adrenal Cortical Carcinoma : 1999-11-03 : Drug: doxorubicin, vincristine, and etoposide with mitotane Active, not recruiting : Activity of Abiraterone Acetate in the Management of Cushing's Syndrome in Patients With Adrenocortical Carcinoma : Cushing Syndrome Adrenocortical Carcinoma : 2017-04-26 : Drug: Abiraterone Acetate Cohort 1: <<< Previous | Next >>>